Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AP214 in Patients Undergoing Cardiac Surgery
NCT00628264Phase 2Terminated
- Sponsor
- Action Pharma A/S
- Start
- Mar 2008
- Primary completion
- Jun 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of modimelanotide in acute kidney injury (AKI), sponsored by Action Pharma A/S. Started Mar 2008; status: terminated.
02
Drugs
modimelanotide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT00628264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628264.